96-6942. Food Labeling: Nutrient Content Claim for ``Extra''  

  • [Federal Register Volume 61, Number 57 (Friday, March 22, 1996)]
    [Rules and Regulations]
    [Pages 11730-11731]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-6942]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 101
    
    [Docket No. 94P-0216]
    
    
    Food Labeling: Nutrient Content Claim for ``Extra''
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending its food 
    labeling regulations to include the term ``extra'' as a synonym for the 
    term ``added.'' This action is in response to FDA's decision to grant a 
    citizen petition for the synonym filed by Darigold, Inc. FDA concludes 
    that the term ``extra'' is a clear and unambiguous synonym for ``more'' 
    and is consistent with the term ``added.''
    
    DATES: The regulation is effective March 22, 1996; comments by April 
    22, 1996.
    
    ADDRESSES: Submit written comments to the Dockets Management Branch 
    (HFA-305), 12420 Parklawn Dr., rm 1-23, Rockville, MD 20857.
    FOR FURTHER INFORMATION CONTACT: Joyce J. Saltsman, Center for Food 
    Safety and Applied Nutrition (HFS-165), Food and Drug Administration, 
    200 C St. SW., Washington, DC 20204, 202-205-5916.
    
    SUPPLEMENTARY INFORMATION:
        Section 403(r)(4) of the Federal Food, Drug, and Cosmetic Act (the 
    act) provides that any person may petition the Secretary of Health and 
    Human Services (and, by delegation, FDA) to approve nutrient content 
    claims that are not specifically provided for in FDA's regulations. In 
    the Federal Register of January 6, 1993 (58 FR 2302), FDA published a 
    final rule entitled ``Food Labeling: Nutrient Content Claims, General 
    Principles, Petitions, Definition of Terms; Definitions of Nutrient 
    Content Claims for the Fat, Fatty Acid, and Cholesterol Content of 
    Food'' (hereinafter referred to as ``nutrient content claims final 
    rule''). That final rule, among other things, defined specific nutrient 
    content claims that included the terms ``good source,'' ``high,'' and 
    ``more'' (Sec. 101.54 (21 CFR 101.54)), and established procedures for 
    the submission and review of petitions regarding the use of nutrient 
    content claims (Sec. 101.69 (21 CFR 101.69)). Section 101.69(n) 
    establishes the procedures to petition for use of a synonymous term.
        On March 21, 1995, FDA received a petition from Darigold, Inc., 
    P.O. Box 79007, Seattle, WA 98119, to establish the term ``extra'' as a 
    synonym for the term ``more'' (Ref. 1). In accordance with procedures 
    established in Sec. 101.69(n), FDA concluded that the term ``extra'' is 
    a clear and unambiguous synonym for ``more'' and, in particular, is 
    consistent with the term ``added.'' To evaluate whether the term 
    ``extra'' and existing terms, such as ``more'' and ``added,'' have the 
    same meaning, FDA reviewed definitions for the term ``extra'' in 
    current dictionaries and found that it is common for the term ``extra'' 
    to be defined as ``more than is usual'' and ``additional.'' Both 
    meanings clearly relate ``extra'' to the defined terms ``more'' and 
    ``added.'' Based on this information, FDA concluded that the term 
    ``extra'' would be commonly understood to have the same meaning as 
    ``more'' and ``added.'' It advised the firm of this in a letter dated 
    October 30, 1995 (Ref.2). The agency also explained in the October 30 
    letter that the term ``extra'' is most closely synonymous with the term 
    ``added'' in that it suggests that the labeled food has been altered 
    compared to a similar reference food. Therefore, the agency concluded 
    that the term ``extra'' as a relative claim must be used in the same 
    way that the term ``added'' is used, as specified under 
    (Sec. 101.13(j)(1)(i)(B) (21 CFR 101.13(j)(1)(i)(B)).
        In Sec. 101.69(n)(4), FDA stated that as soon as practicable 
    following the agency's decision to either grant or deny a petition for 
    a synonymous term, it would publish a notice in the Federal Register 
    informing the public of its decision, and that if it grants the 
    petition, FDA will list the term in its nutrient content claims 
    regulation. Therefore, in this document, the agency is amending 
    Secs. 101.13(j) and 101.54(e) to include the term ``extra'' as a 
    synonym for the term ``added.''
    
    I. References
    
        The following references have been placed on display in the Dockets 
    Management Branch (address above) and may be seen by interested persons 
    between 9 a. m. and 4 p. m., Monday through Friday.
        1. Darigold, Inc., ``Petition for Synonymous Term `Extra','' March 
    18, 1994 [CP1].
    
    [[Page 11731]]
    
        2. Scarbrough, F. Edward, CFSAN, FDA, Letter to Douglas C. 
    Marshall, Darigold, Inc., October 30, 1995 [PAV1].
    
    II. Environmental Impact
    
        The agency has determined under 21 CFR 25.24(a)(11) that this 
    action is of a type that does not individually or cumulatively have a 
    significant effect on the human environment. Therefore, neither an 
    environmental assessment nor an environmental impact statement is 
    required.
    
    III. Analysis of Impact
    
         FDA has examined the economic implications of the final rule 
    amending 21 CFR part 101 as required by Executive Order 12866 and the 
    Regulatory Flexibility Act (Pub. L. 96-354). Executive Order 12866 
    directs agencies to assess all costs and benefits of available 
    regulatory alternatives and, when regulation is necessary, to select 
    regulatory approaches which maximize net benefits (including potential 
    economic, environmental, public health and safety effects; distributive 
    impacts; and equity). The Regulatory Flexibility Act requires analyzing 
    options for regulatory relief for small businesses. This rule provides 
    added flexibility to existing rules governing nutrient content claims. 
    FDA finds that this final rule is not a significant rule as defined by 
    Executive Order 12866. In addition, in accordance with the Regulatory 
    Flexibility Act, the agency certifies that the final rule will not have 
    a significant impact on a substantial number of small businesses.
    
    IV. Paperwork Reduction Act
    
        This rule contains no information collection or recordkeeping 
    requirements under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 
    et. seq.).
    
    V. Public Comment
    
        FDA, for good cause, finds that this final rule is announcing an 
    agency decision reached in accordance with a procedure established by 
    statute, and that notice and public procedure thereon are unnecessary. 
    However, in accordance with 21 CFR 10.40(e)(1), FDA is providing 30 
    days for comment on whether the announced action should be modified or 
    revoked.
        Interested persons may, on or before April 22, 1996, submit to the 
    Dockets Management Branch (address above) written comments regarding 
    this proposal. Two copies of any comments are to be submitted, except 
    that individuals may submit one copy. Comments are to be identified 
    with the docket number found in brackets in the heading of this 
    document. Received comments may be seen in the office above between 9 
    a.m. and 4 p.m., Monday through Friday.
    
    List of Subjects in 21 CFR Part 101
    
        Food labeling, Nutrition, Reporting and recordkeeping requirements.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
    101 is amended as follows:
    
    PART 101--FOOD LABELING
    
         1. The authority citation for 21 CFR part 101 continues to read as 
    follows:
    
        -Authority: Secs. 4, 5, 6 of the Fair Packaging and Labeling Act 
    (15 U.S.C. 1453, 1454, 1455); secs. 201, 301, 402, 403, 409, 701 of 
    the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 342, 
    343, 348, 371).
    
    Sec. 101.13   [Amended]
    
        2. Section 101.13 Nutrient content claims--general principles is 
    amended in paragraph (j)(1)(i)(B) by adding the word ``extra,'' before 
    the word ``fortified''.
    
    
    Sec. 101.54   [Amended]
    
        3. Section 101.54 Nutrient content claims for ``good source,'' 
    ``high,'' and ``more,'' is amended in the first sentence of the 
    introductory text of paragraphs (e)(1) and (e)(2) by removing the words 
    ```enriched,' and `added''', and adding in their place the words 
    ```enriched,' `added,' and `extra'''.
    
        Dated: March 14, 1996.
    William B. Schultz,
    Deputy Commissioner for Policy.
    [FR Doc. 96-6942 Filed 3-21-96; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Effective Date:
3/22/1996
Published:
03/22/1996
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
96-6942
Dates:
The regulation is effective March 22, 1996; comments by April 22, 1996.
Pages:
11730-11731 (2 pages)
Docket Numbers:
Docket No. 94P-0216
PDF File:
96-6942.pdf
CFR: (2)
21 CFR 101.13
21 CFR 101.54